Investment Analysts’ downgrades for Monday, November 9th: Akebia Therapeutics (NASDAQ:AKBA) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating. Amrize (NYSE:AMRZ) was downgraded by analysts at Berenberg Bank from a buy rating to a hold rating. They currently have $46.00 target price on the stock, down from their […]

Investment Analysts’ downgrades for Tuesday, October 27th: Abbott Laboratories (NYSE:ABT) was downgraded by analysts at Argus from a buy rating to a hold rating. Artiva Biotherapeutics (NASDAQ:ARTV) was downgraded by analysts at Wedbush from an outperform rating to a neutral rating. Wedbush currently has $4.00 price target on the stock. Artiva Biotherapeutics (NASDAQ:ARTV) was downgraded […]